文献速递流行病学与生物统计基础与转化研究

焦虑障碍综述:机制、共病与治疗现状

Anxiety disorders.
PubMed 文献 · Lancet · 2021-02-11

焦虑障碍是最常见的精神障碍,多在成年早期前起病,核心特征为持续性过度恐惧、焦虑或回避。遗传与环境因素及其表观遗传关系影响风险,常与抑郁及躯体疾病共病。循证心理治疗(尤其认知行为疗法)与5-羟色胺能药物均有效,但预防措施与难治性病例仍待解决。

要点

  • 焦虑障碍常见且多与抑郁、躯体疾病共病,共病提示症状更重、治疗更难。
  • 认知行为疗法与5-羟色胺能药物均为有效治疗,应让患者参与治疗选择。
  • 目前无持久预防措施,治疗抵抗常见,精准医学是个体化治疗方向。

核心结论

  • 及时准确识别并给予充分治疗、必要时扩大治疗规模,是减轻焦虑障碍疾病负担的最佳途径。

研究设计与样本

  • 本文为综述,围绕焦虑障碍的患病特点、核心特征、神经环路、遗传与环境及表观遗传风险、共病与治疗进行汇总。

主要发现

  • 焦虑障碍是最常见的精神障碍组,通常起病于成年早期前或成年早期。
  • 核心特征为对感知威胁的过度恐惧和焦虑或回避,持续存在并造成功能损害。
  • 焦虑障碍涉及应对危险的大脑环路功能异常。
  • 风险受遗传因素、环境因素及其表观遗传关系影响。
  • 焦虑障碍常彼此共病,也常与抑郁等精神障碍及躯体疾病共病,共病通常意味着症状更重、临床负担更大、治疗更困难。

关键数值与推荐

  • 循证心理治疗(尤其认知行为疗法)与精神活性药物(尤其5-羟色胺能化合物)均有效,可促进患者参与治疗决策。
  • 目前尚无持久的预防措施,且治疗抵抗常见。

临床怎么用

  • 临床应尽早准确识别焦虑障碍并给予充分治疗,必要时扩大治疗规模。
  • 治疗选择中应结合循证心理治疗与5-羟色胺能药物,并促进患者参与决策。

局限性

  • 目前无持久预防措施,治疗抵抗常见,临床需求尚未满足。
  • 未来需个体化、更有效的精准医学治疗路径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anxiety disorders form the most common group of mental disorders and generally start before or in early adulthood. Core features include excessive fear and anxiety or avoidance of perceived threats that are persistent and impairing. Anxiety disorders involve dysfunction in brain circuits that respond to danger. Risk for anxiety disorders is influenced by genetic factors, environmental factors, and their epigenetic relations. Anxiety disorders are often comorbid with one another and with other mental disorders, especially depression, as well as with somatic disorders. Such comorbidity generally signifies more severe symptoms, greater clinical burden, and greater treatment difficulty. Reducing the large burden of disease from anxiety disorders in individuals and worldwide can be best achieved by timely, accurate disease detection and adequate treatment administration, scaling up of treatments when needed. Evidence-based psychotherapy (particularly cognitive behavioural therapy) and psychoactive medications (particularly serotonergic compounds) are both effective, facilitating patients' choices in therapeutic decisions. Although promising, no enduring preventive measures are available, and, along with frequent therapy resistance, clinical needs remain unaddressed. Ongoing research efforts tackle these problems, and future efforts should seek individualised, more effective approaches for treatment with precision medicine.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021. PMID: 33581801. doi:10.1016/S0140-6736(21)00359-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。